KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer

被引：0
|
作者：
Y Kawamoto
K Tsuchihara
T Yoshino
N Ogasawara
M Kojima
M Takahashi
A Ochiai
H Bando
N Fuse
M Tahara
T Doi
H Esumi
Y Komatsu
A Ohtsu
机构：
[1] Hokkaido University Graduate School of Medicine,Department of Gastroenterology
[2] Cancer Physiology Project,Department of Gastroenterology and Gastrointestinal Oncology
[3] Research Center for Innovative Oncology,Department of Cancer Center
[4] National Cancer Center Hospital East,Pathology Division
[5] National Cancer Center Hospital East,undefined
[6] Hokkaido University Hospital,undefined
[7] Research Center for Innovative Oncology,undefined
[8] National Cancer Center Hospital East,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
colorectal cancer; genomic biomarker; anti-EGFR antibody; oxaliplatin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：340 / 344
页数：4
相关论文
共 50 条
  • [21] Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
    Lavacchi, Daniele
    Fancelli, Sara
    Roviello, Giandomenico
    Castiglione, Francesca
    Caliman, Enrico
    Rossi, Gemma
    Venturini, Jacopo
    Pellegrini, Elisa
    Brugia, Marco
    Vannini, Agnese
    Bartoli, Caterina
    Cianchi, Fabio
    Pillozzi, Serena
    Antonuzzo, Lorenzo
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
    Li, Zi-Nan
    Zhao, Lin
    Yu, Li-Feng
    Wei, Min-Jie
    GASTROENTEROLOGY REPORT, 2020, 8 (03): : 192 - 205
  • [23] Genomic study of KRAS/NRAS mutations of metastatic colorectal cancer in eastern Algeria
    Mazouzi, Khaoula
    CANCER RESEARCH, 2017, 77 (22)
  • [24] Clinical and Functional Characterization of Atypical KRAS/NRAS Mutations in Metastatic Colorectal Cancer
    Loree, Jonathan M.
    Wang, Yucai
    Syed, Muddassir A.
    Sorokin, Alexey, V
    Coker, Oluwadara
    Xiu, Joanne
    Weinberg, Benjamin A.
    Vanderwalde, Ari M.
    Tesfaye, Anteneh
    Raymond, Victoria M.
    Miron, Benjamin
    Tarcic, Gabi
    Zelichov, Ori
    Broaddus, Russell R.
    Ng, Patrick Kwok Shing
    Jeong, Kang Jin
    Tsang, Yiu Huen
    Mills, Gordon B.
    Overman, Michael J.
    Grothey, Axel
    Marshall, John L.
    Kopetz, Scott
    CLINICAL CANCER RESEARCH, 2021, 27 (16) : 4587 - 4598
  • [25] Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer
    Neumann, Jens
    Zeindl--Eberhart, Evelyn
    Kirchner, Thomas
    Jung, Andreas
    PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (12) : 858 - 862
  • [26] Prognostic impact of KRAS driver mutations and GSTT1 expression in colorectal cancer to FOLFOX treatment
    Wang, Jessie Jingjing
    Mao, Binchen
    Guo, Sheng
    Ouyang, Davy Xuesong
    Li, Henry Qixiang
    CANCER RESEARCH, 2019, 79 (13)
  • [27] KRAS, BRAF and PIK3CA mutations in human colorectal cancer: Relationship with metastatic colorectal cancer
    Li, Hong-Tao
    Lu, Yuan-Yuan
    An, Yan-Xin
    Wang, Xin
    Zhao, Qing-Chuan
    ONCOLOGY REPORTS, 2011, 25 (06) : 1691 - 1697
  • [28] Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer
    Taniguchi, Fumitaka
    Nyuya, Akihiro
    Toshima, Toshiaki
    Yasui, Kazuya
    Mori, Yoshiko
    Okawaki, Makoto
    Kishimoto, Hiroyuki
    Umeda, Yuzo
    Fujiwara, Toshiyoshi
    Tanioka, Hiroaki
    Yamaguchi, Yoshiyuki
    Goel, Ajay
    Nagasaka, Takeshi
    FUTURE SCIENCE OA, 2021, 7 (10):
  • [29] The dynamics of telomere length in primary and metastatic colorectal cancer lesions
    Kroupa, Michal
    Kubecek, Ondrej
    Tomasova, Kristyna
    Hanak, Petr
    Krupova, Marketa
    Cervena, Klara
    Siskova, Anna
    Rosendorf, Jachym
    Hosek, Petr
    Vodickova, Ludmila
    Vodicka, Pavel
    Liska, Vaclav
    John, Stanislav
    Vymetalkova, Veronika
    Petera, Jiri
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [30] The dynamics of telomere length in primary and metastatic colorectal cancer lesions
    Kroupa M.
    Kubecek O.
    Tomasova K.
    Hanak P.
    Krupova M.
    Cervena K.
    Siskova A.
    Rosendorf J.
    Hosek P.
    Vodickova L.
    Vodicka P.
    Liska V.
    John S.
    Vymetalkova V.
    Petera J.
    Scientific Reports, 13 (1)
12345